Cogent Biosciences Inc.
COGT | NASDAQ
$32
+$0.50 (+1.59%)
At close: Sep 21, 2026, 4:00 PM ET
$32.20
+$0.20 (+0.63%)
Pre-market:
Sep 22, 2026, 8:05 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 7.87M |
Cost of Revenue | 4.62M | n/a | n/a | n/a | n/a | 25.74M |
Gross Profit | -4.62M | n/a | n/a | n/a | n/a | -17.87M |
Operating Income | -333.36M | -275.94M | -208.13M | -147.84M | -75.55M | -82.2M |
Interest Income | 14.69M | 18.09M | 13.08M | 3.99M | 467K | 144K |
Pretax Income | -328.94M | -255.86M | -192.41M | -140.24M | -72.27M | -74.81M |
Net Income | -328.94M | -255.86M | -192.41M | -140.24M | -72.27M | -74.81M |
Selling & General & Admin | 63.58M | 43.28M | 34.38M | 26.21M | 19.64M | 17.42M |
Research & Development | 269.78M | 232.66M | 173.76M | 121.63M | 55.91M | 72.65M |
Other Expenses | -4.62M | n/a | n/a | n/a | n/a | -25.74M |
Operating Expenses | 328.74M | 275.94M | 208.13M | 147.84M | 75.55M | 64.33M |
Interest Expense | 3.06M | n/a | n/a | 3.99M | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 333.36M | 275.94M | 208.13M | 147.84M | 75.55M | 90.07M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 160.98M | 110.46M | 79.66M | 58.74M | 38.73M | 11.08M |
Shares Outstanding (Diluted) | 160.98M | 110.46M | 79.66M | 58.74M | 38.73M | 11.08M |
EPS (Basic) | -2.04 | -2.32 | -2.42 | -2.26 | -1.85 | -6 |
EPS (Diluted) | -2.04 | -2.32 | -2.42 | -2.26 | -1.85 | -6 |
EBITDA | -321.26M | -251.51M | -188.82M | -130.37M | -70.28M | -34.57M |
EBIT | -325.88M | -255.86M | -192.41M | -136.25M | -72.27M | -35.29M |
Depreciation & Amortization | 4.62M | 4.35M | 3.59M | 5.88M | 1.99M | 720K |
Add to Watchlist
Select watchlists to add or remove COGT